Table 1.
Variable | Overall Cohort |
Total Adrenalectomy | Partial Adrenalectomy | p |
---|---|---|---|---|
Age at surgery (median, IQR) | 54 (44–65) | 54 (44.5–63) | 57 (43.5–67.5) | 0.408 |
Follow-up (months, median, range) | 42 (27–54) | 41 (24–50) | 46 (32.7–57.5) | 0.223 |
Gender (n, %) | 0.519 | |||
Male | 36 (40%) | 23 (37.7%) | 13 (44.8%) | |
Female | 54 (60%) | 38 (62.3%) | 16 (55.2%) | |
ASA score (n, %) | 0.763 | |||
1–2 | 73 (81.1%) | 50 (82%) | 23 (79.3%) | |
3–4 | 17 18.9% | 11 (18%) | 6 (20.7%) | |
Adrenal mass size (cm, n, IQR) | 3 (2–5) | 4.2 (2.35–6) | 2.7 (1.8–2.85) | 0.001 |
Side (n, %) | 0.001 | |||
Left | 45 (50%) | 23 (37.7%) | 22 (75.9%) | |
Rigth | 45 (50%) | 38 (62.3%) | 7 (24.1%) | |
Preoperative Hypertension (n, %) | 0.456 | |||
Yes | 80 (88,8%) | 3 (86.8%) | 27 (93,1%) | |
No | 10 (11,2%) | 8 (13.2%) | 2 (6,9 %) | |
Preoperative Hypokalemia (n, %) | 0.184 | |||
Yes | 63 (70%) | 21 (65.6%) | 6 (20.7%) | |
No | 27 (30%) | 40 (34.4%) | 23 (79.3%) | |
Number of drugs (n, %) | 0.676 | |||
One class medication | 9 (10%) | 7 (11.4%) | 2 (6.8%) | |
No drugs | 50 (55.5%) | 32 (52.4%) | 18 (62%) | |
Combined class medication (≥2) | 31 (34.5%) | 22 (36%) | 9 (31.2%) | |
Preoperative TIS score (median, IQR) |
0.5 (0.25–1) | 0.5 (0.25–1.09) | 0.5 (0.25–1) | 0.989 |